Active surveillance for carbapenem- resistant enterobacteriaceae using stool specimens submitted for testing for Clostridium difficile

David B. Banach, Jeannette Francois, Stephanie Blash, Gopi Patel, Stephen G. Jenkins, Vincent LaBombardi, Barry N. Kreiswirth, Arjun Srinivasan, David P. Calfee

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Abstract

Active surveillance to identify asymptomatic carriers of carbapenemresistant Enterobacteriaceae (CRE) is a recommended strategy for CRE control in healthcare facilities. Active surveillance using stool specimens tested for Clostridium difficile is a relatively low-cost strategy to detect CRE carriers. Further evaluation of this and other risk factor-based active surveillance strategies is warranted.

Original languageEnglish (US)
Pages (from-to)82-84
Number of pages3
JournalInfection Control and Hospital Epidemiology
Volume35
Issue number1
DOIs
StatePublished - Jan 2014

All Science Journal Classification (ASJC) codes

  • Epidemiology
  • Microbiology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Active surveillance for carbapenem- resistant enterobacteriaceae using stool specimens submitted for testing for Clostridium difficile'. Together they form a unique fingerprint.

Cite this